Two biggest charitable funds in Kazakhstan signed an agreement for research on causes and risk factors concerning infantile cerebral paralysis.
Last December, the city of Almaty hosted a press-conference in the course of which the representatives of Asyl Miras, the major charitable fund that belongs to Bulat Utemuratov, one of the most recognizable personalities in Kazakhstan, and the voluntary association “Miloserdie” (Compassion), which is run by Aruzhan Sanin, a TV celebrity and social activist, signed an agreement which indicated that more than $15.000 will be allocated for the research and assessment of risk factors for such a terrible disease as infantile cerebral paralysis.
The research will concern all stages of infant’s life: prenatal, intranatal, and postnatal. Aruzhan Sanin expressed her deep concern about the increasing number of children who require special treatment. She told that a few years ago, the foundation had an opportunity to treat children with ICP in Europe and the United States, but now there are way more applications from desperate parents than they can handle. So, they began looking for ways to organize treatment in Kazakhstan. That is why the foundation has actively sought for help from the business community and other charitable foundations and found the best partnership possible because when it comes to helping children with special needs, there is no one more supportive than Bulat Utemuratov and his foundation Asyl Miras.
The strategic objective of the given research is to elaborate recommendations for the Ministry of Health Of Kazakhstan regarding the preventative measure that can be applied at the early stages in order to discourage the development of infantile cerebral paralysis due to physician’s negligence.
Bulat Utemuratov, the founder of Asyl Miras, also said that it is very important to create all the necessary conditions for the timely and effective rehabilitation of children with infantile cerebral paralysis and prepare the basis for profound research of the causes of this disease. That is why, upon request from the Ministry of Health of Kazakhstan, his foundation decided to support their new partners in their research work and help them develop a special program for children with ICP. Mr. Utemuratov is certain that their consolidated effort will play a decisive role in resolving this acute problem.